Undetected Peripheral Arterial Disease Among Older Adults With Alzheimer's Disease and Other Dementias

Overview

Journal Am J Alzheimers Dis Other Demen

Publisher Sage Publications

Specialty Neurology

Date 2017 Aug 9

PMID 28786294

Citations 7

Authors

Ilker Tasci

Umut Safer

Mehmet Ilkin Naharci

Mustafa Gezer

Orhan Demir

Ergun Bozoglu

Huseyin Doruk

Affiliations

Soon will be listed here.

Abstract

Background: Peripheral arterial disease (PAD) was reported to increase the risk of dementia(s) even more than stroke. We assessed the prevalence of PAD in a group with definite diagnosis of dementia.

Methods: Patients aged 65 years or older with Alzheimer's disease (AD), vascular dementia (VaD), or AD-VaD were enrolled (n = 162, mean age: 78.87 [6.05] years). An age- and gender-matched control group was also included (n = 190). Peripheral arterial disease was diagnosed by the ankle-brachial index.

Results: Frequency of PAD among patients with and without dementia was 35.2% and 16.3%, respectively ( P < .001), being similar among different types of dementia. After adjustment for covariates, dementia (odds ratio: 2.41, 95% confidence interval: 1.34-4.32; P = .003) was among the predictors of PAD diagnosis along with older age, female gender, and diabetes.

Conclusions: The prevalence of PAD was more than double in patients with dementia, with no difference among AD, VaD, and AD-VaD types.

Citing Articles

Sarcopenia and diabetes-induced dementia risk.

Sun M, Lu Z, Chen W, Wu S, Zhang J Brain Commun. 2024; 6(1):fcad347.

PMID: 38179233 PMC: 10766377. DOI: 10.1093/braincomms/fcad347.

Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment.

Rajeev V, Chai Y, Poh L, Selvaraji S, Fann D, Jo D Acta Neuropathol Commun. 2023; 11(1):93.

PMID: 37309012 PMC: 10259064. DOI: 10.1186/s40478-023-01590-1.

Rapamycin restores peripheral blood flow in aged mice and in mouse models of atherosclerosis and Alzheimer's disease.

Van Skike C, DeRosa N, Galvan V, Hussong S Geroscience. 2023; 45(3):1987-1996.

PMID: 37052770 PMC: 10400743. DOI: 10.1007/s11357-023-00786-6.

Microvascular dysfunction and neurovascular uncoupling are exacerbated in peripheral artery disease, increasing the risk of cognitive decline in older adults.

Owens C, Mukli P, Csipo T, Lipecz A, Silva-Palacios F, Dasari T Am J Physiol Heart Circ Physiol. 2022; 322(6):H924-H935.

PMID: 35333116 PMC: 9037702. DOI: 10.1152/ajpheart.00616.2021.

Cognitive decrement in older adults with symptomatic peripheral artery disease.

Gardner A, Montgomery P, Wang M, Shen B, Casanegra A, Silva-Palacios F Geroscience. 2021; 43(5):2455-2465.

PMID: 34498199 PMC: 8599571. DOI: 10.1007/s11357-021-00437-8.

References

Lenart N, Brough D, Denes A . Inflammasomes link vascular disease with neuroinflammation and brain disorders. J Cereb Blood Flow Metab. 2016; 36(10):1668-1685. PMC: 5076791. DOI: 10.1177/0271678X16662043. View

Deschaintre Y, Richard F, Leys D, Pasquier F . Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009; 73(9):674-80. DOI: 10.1212/WNL.0b013e3181b59bf3. View

de Bruijn R, Ikram M . Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med. 2014; 12:130. PMC: 4226863. DOI: 10.1186/s12916-014-0130-5. View

Janelidze S, Stomrud E, Palmqvist S, Zetterberg H, van Westen D, Jeromin A . Plasma β-amyloid in Alzheimer's disease and vascular disease. Sci Rep. 2016; 6:26801. PMC: 4886210. DOI: 10.1038/srep26801. View

Rafnsson S, Deary I, Fowkes F . Peripheral arterial disease and cognitive function. Vasc Med. 2009; 14(1):51-61. DOI: 10.1177/1358863X08095027. View

McDermott M, Greenland P, Liu K, Guralnik J, Criqui M, Dolan N . Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001; 286(13):1599-606. DOI: 10.1001/jama.286.13.1599. View

Breteler M, Claus J, Grobbee D, Hofman A . Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994; 308(6944):1604-8. PMC: 2540432. DOI: 10.1136/bmj.308.6944.1604. View

Tasci I, Verim S, Kabul H, Aydogdu A . Ankle brachial index as a predictor of subclinical atherosclerosis in the elderly. Int J Cardiol. 2012; 160(2):147. DOI: 10.1016/j.ijcard.2012.05.076. View

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View

10.

Bozkurt A, Tasci I, Tabak O, Gumus M, Kaplan Y . Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis--CAREFUL study: a national, multi-center, cross-sectional observational study. BMC Cardiovasc Disord. 2011; 11:4. PMC: 3033857. DOI: 10.1186/1471-2261-11-4. View

11.

de la Torre J . Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004; 3(3):184-90. DOI: 10.1016/S1474-4422(04)00683-0. View

12.

Newman A, Fitzpatrick A, Lopez O, Jackson S, Lyketsos C, Jagust W . Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005; 53(7):1101-7. DOI: 10.1111/j.1532-5415.2005.53360.x. View

13.

Hofman A, Ott A, Breteler M, Bots M, Slooter A, Van Harskamp F . Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997; 349(9046):151-4. DOI: 10.1016/S0140-6736(96)09328-2. View

14.

Blom K, Vaartjes I, Peters S, Koek H . The influence of vascular risk factors on cognitive decline in patients with Alzheimer's disease. Maturitas. 2014; 79(1):96-9. DOI: 10.1016/j.maturitas.2014.06.017. View

15.

Santos C, Snyder P, Wu W, Zhang M, Echeverria A, Alber J . Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimers Dement (Amst). 2017; 7:69-87. PMC: 5328683. DOI: 10.1016/j.dadm.2017.01.005. View

16.

Faxon D, Creager M, Smith Jr S, Pasternak R, Olin J, Bettmann M . Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2004; 109(21):2595-604. DOI: 10.1161/01.CIR.0000128517.52533.DB. View

17.

van Oijen M, de Jong F, Witteman J, Hofman A, Koudstaal P, Breteler M . Atherosclerosis and risk for dementia. Ann Neurol. 2007; 61(5):403-10. DOI: 10.1002/ana.21073. View

18.

Pluta R, Ulamek M, Jablonski M . Alzheimer's mechanisms in ischemic brain degeneration. Anat Rec (Hoboken). 2009; 292(12):1863-81. DOI: 10.1002/ar.21018. View

19.

Laurin D, Masaki K, White L, Launer L . Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study. Circulation. 2007; 116(20):2269-74. DOI: 10.1161/CIRCULATIONAHA.106.686477. View

20.

Regensteiner J, Hiatt W, Coll J, Criqui M, Treat-Jacobson D, McDermott M . The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med. 2008; 13(1):15-24. DOI: 10.1177/1358863X07084911. View